Effect of cystoscopy and urethral dilatation vs cystoscopy alone with tamsulosin in women with voiding dysfunction: a retrospective comparative study

Background:To analyze the data of cystoscopy and urethral dilatation with tamsulosin therapy in comparison to cystoscopy alone with tamsulosin in women with voiding dysfunction and overactivity. Methods: Retrospective data of women with overactive bladder symptoms and a maximum ow rate of <15 mL/sec on a voided volume of over 150 mLand/or a postvoid residual volume >100 mLwho underwent dilatation and tamsulosin therapy were compared with the patients who had undergone cystoscopy and tamsulosin. Symptom assessment and urodynamic evaluation was done at baseline, 6 weeks and 6 months postoperatively. Results: In total, 67 patients (34 in dilatation and tamsulosin [group A] and 33 in cystoscopy and tamsulosin [group]) were included in this study. After 6 weeks and 6 months, the American urological association symptom score decreased by 12.46 and 9.84 in group A and by 8.88 and 6.55 in group B. Changes in voided volume, maximum ow rate and post-void residual volume at 6 weeks and 6 months were signicant in both the groups (P=0.001). On comparing both the groups, improvements in all the parameters were numerically higher in group Aat 6 weeks. Mild bleeding was seen in ve cases of group A, no other adverse events were noted. Conclusion: A signicant improvement in clinical as well as urodynamic parameters was seen in both the groups individually at both 6 weeks and 6 months posttreatment. However, the intergroup comparison revealed that the addition of urethral dilatation to cystoscopy fares better than cystoscopy alone but for short term.